Hosted on MSN
Boston Sci Q2 Revenue Up 23 Percent
This investment supported new clinical trials and developmental work for key platforms, such as next-generation pulsed field ablation catheters and pipeline products ... Revenue and net income ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results